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Sector of the Economy
Jörg-Peter Weiss, Stephan Raab and Joachim Schintke
The pharmaceutical industry employs around 106 000 people and produces
a good 9 billion euros or 2.5% of value added in the manufacturing sector in
Germany. But it contributes a bigger part to value added and employment
in the economy as a whole than these figures show. Its particular role
results from the fact that almost its entire output (96%) goes direct to end
user (final demand), while demand for its products is subject to the special
regulations in the health system.
With its purchases of intermediate products and capital goods the phar-
maceutical industry gives rise to production and employment effects in
nearly every area of production. That applies particularly to high quality
services, like business-related services, research and development, leasing,
services in the real estate and housing sector and data processing and data
bank services. State regulations in the health system thus also have an
effect in other sectors of the economy.
This article presents analyses by DIW Berlin of the linkages between
the pharmaceutical industry and the rest of the economy.1 It shows that
deliveries by the pharmaceutical sector to final demand in private house-
holds and public authorities (the social insurance institutions, especially the
compulsory health insurance) and abroad have considerable indirect pro-
duction effects in other sectors of the economy, amounting to about 60% of
the direct deliveries by the pharmaceutical industry to final demand. So for
every person employed in the pharmaceutical industry one other person is
employed in the rest of the economy.
1  This article gives the results of a study by DIW Berlin for the Verband Forschender Arznei-
mittelhersteller, cf. J.-P. Weiss, S. Raab and J. Schintke: 'Die Pharmazeutische Industrie im
gesamtwirtschaftlichen Kontext: Ausstrahlung auf Produktion und Beschäftigung in den Zu-
lieferbereichen', in: DIW Berlin: Politikberatung kompakt, vol. 4 (www.diw.de/deutsch/
produkte/publikationen/diwkompakt/2004/index/html). This article differs from the results
published there in the employment effects in 2000 and 2002. This is because the Federal Statis-
tical Office revised the employment figures for the pharmaceutical industry and the rest of the
chemical industry caused by the DIW Berlin study. 
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The position of the pharmaceutical 
industry in the German economy 
Germany traditionally has a strong position in high-tech
goods, but the peak technology sector is relatively
weak.2 The particular position of the pharmaceutical
industry in the structure of German production is due to
three factors. Firstly, it is distinguished by particularly
high research intensity, and it is a peak technology sec-
tor. Secondly, it is one of the sources of medical progress
in industry beside medical equipment, and so it contrib-
utes to the efficiency of the health system, which
employs 10.5% of the total workforce. This sector, with
its related industries, is the focus of public discussion at
present, on account of its dynamic growth and the
resultant rise in expenditure by the health insurance
institutes, causing increases in their contribution rates.3
Thirdly, production by the industries related to the
health system is growing at an above-average rate, and
they are one of the few sectors of industry that have
increased the number of employed persons in the last
ten years.
The pharmaceutical industry is one of the leading
branches in German industry in research and develop-
ment intensity, together with aircraft and spacecraft
construction, and radio, television and communications
technology. The share of its internal R&D expenditure
in the value of production for sale was 13.7% in 2001;4
the aircraft and spacecraft sector spent 13.2%, and
radio, television and communications technology
10.9%.5 Its contributions to gross domestic product
(gross value added) and employment, however, are
small compared with the high-tech sectors, like the rest
of the chemical industry or automotive construction (cf.
figure 1).
However, the pharmaceutical industry _ like the
other industry of importance for the health system, med-
2  Cf. Dieter Schumacher, H. Legler and B. Gehrke: 'Gute Position Deut-
schlands bei forschungs- und wissensintensiven Produkten gefährdet',
in: Wochenbericht des DIW Berlin, no. 31/2003, p. 487. In this article
peak technology goods are groups with a high share, more than 8.5%,
of research and development in turnover, and high-tech goods are
groups with an R&D share in turnover of between 3.5% and 8.5%. 
3  Cf. Volker Meinhardt and Erika Schulz: 'Kostenexplosion im Gesund-
heitswesen?' In: Wochenbericht des DIW Berlin, no. 7/2003, pp. 105ff.
4  Internal R&D expenditure is expenditure within the firm on research
and development. 
5  Cf. C. Grenzmann, R. Marquardt, H. Legler, B. Gehrke and U.
Schasse, with contributions from M. Leidman: 'Forschungs- und Ent-
wicklungsaktivitäten der deutschen Wirtschaft', in: Studien zum deut-
schen Innovationssystem, no. 10/2004, p. 26.
Sources: Federal Statistical Office; DIW Berlin calculations.
Figure 1
Gross Value Added and Employment in Selected Research-Intensive Industries in Germany 
in 2002
DIW Berlin 2005
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ical equipment _ is much more expansive than the aver-
age for manufacturing or, to name one example, the
chemical industry (cf. figure 2).
This brief survey of the pharmaceutical industry's
position in the structure of German industry shows that
its importance in the economy as a whole in Germany is
only inadequately described in a comparison of eco-
nomic data like turnover, value added or the number of
persons employed with the corresponding macroeco-
nomic data. Hence, this article examines another impor-
tant aspect, the question what effects the pharmaceuti-
cal industry has on the rest of the economy. To answer
that question the intersectoral dependencies that result
from mutual deliveries and purchases are examined
using an input-output analysis model.6
The pharmaceutical industry's linkages 
through its purchases of intermediate 
products – the input structure
Purchases of intermediate products by the pharmaceuti-
cal industry amount to a good 60% of its production
value and more than half of the purchases are within
Germany. A consideration of the input side shows that
the pharmaceutical industry has linkages with almost
every area of production (cf. tables 1 and 2).
However, there are clear concentrations. A good half
of the purchases of intermediate products in Germany in
2000 were in only three supplier sectors: the chemical
industry, business-related services and research and
development services _ although the level of research
and development within the pharmaceutical industry is
itself high.
The pharmaceutical industry influences production
activity in the rest of the economy not only through its
purchases of intermediate products but also through its
investment activity. In the period considered here, 1995
to 2000, purchases of capital goods grew relatively
much more strongly, from around 1 billion euros to just
under 1.7 billion euros (cf. table 3), than purchases of
intermediate products, which rose from 10.2 billion
euros to 12.7 billion euros.
The value of purchases of intermediate products and
of capital goods is by no means the end of the pharma-
ceutical industry's influence on the economy. On the
contrary, the chemical industry, for instance, in turn
needs intermediate products from crude oil processing,
the electricity industry or manufacturers of foodstuffs,
beverages and tobacco in order to make its deliveries to
the pharmaceutical industry, and these in turn require
intermediate products, e.g. from mining and agriculture
and the manufacturers of metal products.
An input-output analysis, and especially the static
open input-output model, offers a method to answer the
question of to what extent the pharmaceutical industry
causes production effects in its suppliers through its
purchases of intermediate products and capital goods,
and _ again along the chain of intermediate products _ in
6  On the data base and methodology see DIW Berlin: Politikberatung
kompakt, vol. 4, pp. 20ff.
Figure 2
Value Added and Employment in 
Manufacturing in Germany 1995 to 2002
1995 = 100










1995 1996 1997 1998 1999 2000 2001 2002


















Production of pharmaceutical products
Manufacturing


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































.84 DIW Berlin Weekly Report No. 6/2005
their suppliers, so contributing to value added (income)
and employment in a large number of production sec-
tors.
This model also forms the basis for the calculation of
the effects that are indirectly induced in the individual
production sectors of the German economy through the
chain of suppliers of intermediate products by this
industry's direct deliveries of pharmaceutical products
to final demand.
The input-output model enables the share of produc-
tion or gross value added and employment in these pro-
duction sectors to be calculated for 1995 and 2000 that is
caused by demand for capital goods in the pharmaceuti-
cal industry and its deliveries to final demand.
The calculations for 2002 are approximations. They
are based on the assumption that the production coeffi-
cients calculated from the input-output table for 2000
are also valid for the year 2002. This table is used to
determine the production figures of the sectors that
depend on the end-user deliveries regarded as exoge-
nous in the model. Moreover, the input-output calcula-
tion for 2002 contains no figures for final demand and
no data on the number of persons employed, and so
these figures had to be estimated.
Hence some unclarity has to be taken into account in
considering the model calculations for 2002 as these con-
tain estimated data. The year 2002 was chosen as the
latest for the calculations because, as well as the produc-
tion statistics with the statistics on cost structures and
the national accounts, at least some indications were
available for the extrapolation of final demand for phar-
maceuticals and for the estimate of labour coefficients.
Moreover, it is also assumed that the application of the
coefficient matrix for 2000 also provides an acceptable
approximation for 2002.
The effects of the pharmaceutical 
industry on production and 
employment in production sectors
The following section gives the results of the model cal-
culations.
The effects of investment activity by the 
pharmaceutical industry
Investment in fixed capital formation by the pharmaceu-
tical industry induces production in the economy as a
whole to a value around 1.7 times the volume of invest-
ment in the pharmaceutical sector. In 2002 the sector
invested 1.5 billion euros, and this corresponded to pro-
duction in the economy as a whole of 2.6 billion euros.
An estimated 22 000 persons were employed on this pro-
duction and the gross value added amounted to 1.2 bil-
lion euros.
A glance at table 5 shows that production, value
added and employment are also induced in production
sectors that are not directly affected by demand for
investment in the pharmaceutical industry. They
include the chemical industry, energy and water sup-
plies and transport and other services.7
The effects of deliveries by the pharmaceutical 
industry to final demand
Direct deliveries by the pharmaceutical industry to final
demand amounted to 22.1 billion euros in 2002, and the
model calculations show that output of intermediate
products was induced in the producing sectors (indirect
production effects) to the amount of 12.5 billion euros.
That was 56.7% of the value of the direct deliveries. So
deliveries by the pharmaceutical industry to final
demand resulted in a production value totalling 34.6 bil-
lion euros (cf. table 4). Total production induced by the
pharmaceutical industry's deliveries to final demand
amounted to 157% of direct deliveries to final demand.
Table 3
The Effects of Investment in Plant and 
Equipment by the Pharmaceutical Industry on 














In million euros at current prices No. of persons
1995 963 1 667 795 16 893
2000 1 661 2 804 1 288 24 455
2002 1 526 2 572 1 180 21 910
Sources: Federal Statistical Office; DIW Berlin calculations.
7  As a rule negative value added amounts are shown for the banks in
tables 4 and 5. This is only a correction to the national accounts to bal-
ance the assumed charges for banking services, which should actually
be included in the purchases of intermediate products by the other pro-
ducing sectors, so reducing their value added; however, in the method
of accounting used hitherto they have not been included.DIW Berlin Weekly Report No. 6/2005  85
Table  4
Production, Value Added and Employment Induced in Production Sectors by Final Demand for 
Pharmaceutical Products in 2002











 Directly induced effects
12 24.4 Pharmaceutical products 22 094 8 286 101 836
 Indirectly induced effects
1 01 to 05 Agriculture, forestry and fishing 54 25 1 084
2 10 to 14 Mining and quarrying  40 13 623
3 15 Food products and beverages 176 47 1 235
4 16 Tobacco products 000
51 7 T e x t i l e s 32 11 317
6 18 Wearing apparel; furs 106
7 19 Leather and leather products 003
8 20 Wood and products of wood and cork, except furniture; articles of straw and plaiting materials 35 12 298
9 21 Pulp, paper and paper products 280 86 1 442
10 22 Publishing, printing and recorded media 147 67 1 146
11 23 Coke, refined petroleum products and nuclear fuel 130 14 87
12 24.4 Pharmaceutical products 63 24 291
13 24 (ex. 24.4) Chemicals and chemical products, except pharmaceutical products 2 306 644 7 756
14 25 Rubber and plastic products 348 130 2 626
15 26 Glass and other non-metallic mineral products 129 57 1 112
16 27 Basic metals 61 13 300
17 28 Fabricated metal products, except machinery and equipment 358 150 3 306
18 29 Machinery and equipment 98 39 691
19 30 Office machinery and computers 43 9 126
20 31 Electrical machinery and apparatus, etc. 59 24 400
21 32 Radio, television and communication equipment and apparatus 11 3 66
22 33 Medical, precision and optical instruments, watches and clocks 49 23 425
23 34 Motor vehicles, trailers and semi-trailers 11 2 38
24 35 Other transport equipment 31 1 7
25 36 Furniture, other manufactured goods, etc. 5 2 50
26 37 Material recycling 92 4 0
27 40 Electrical energy, gas, steam and hot water and distribution of gas 228 107 815
28 41 Water supply 31 21 157
29 45 Construction; civil engineering and building completion 318 139 4 186
30 50 Sale, maintenance and repair of motor vehicles and motorcycles; retail sale of automotive fuel 64 34 1 053
31 51 Wholesale trade and commission trade, except of motor vehicles and motorcycles 375 227 3 986
32 52 Retail trade, except of motor vehicles and motorcycles; repair of personal and household goods 70 44 1 767
33 55 Hotel and restaurant services 44 19 1 386
34 60 Land transport; transport via pipelines 168 83 2 879
35 61 Water transport services 10 3 18
36 62 Air transport services 99 47 242
37 63 Supporting and auxiliary transport activities; activities of travel agencies 241 80 1 830
38 64 Post and telecommunications 309 190 1 904
39 65 Financial intermediation services, except insurance and pension funding services 380 -27 2 960
40 66 Insurance and pension funding services, except compulsory social security 102 24 423
41 67 Activities auxiliary to financial intermediation 47 25 546
42 70 Real estate activities 588 459 748
43 71 Renting of machinery and equipment without operator and of personal and household goods 696 494 1 232
44 72 Computer and related services 356 264 3 071
45 73 Research and development services 699 348 5 849
46 74 Other business services 2 607 1 838 33 983
47 75 Public administration and defence, compulsory social security services 189 138 3 089
48 80 Education 64 53 1 331
49 85 Health and social work services 21 4 3
50 90 Sewage and refuse disposal, sanitation and similar activities 102 48 542
51 91 Membership organisation services, etc. 59 43 1 322
52 92 Recreational, cultural and sporting services 129 77 1 296
53 93 Other services 104 79 1 873
54 95 Private households 000
55 All production sectors 12 532 6 258 102 016
 Total induced effects
All production sectors 34 626 14 545 203 853
1 Statistical classification of goods related to economic sectors in the European Union. — 2 Calculated using labour coefficients, estimated on the basis of the national accounts
and surveys on cost structures.
Sources: Federal Statistical Office; DIW Berlin calculations.86 DIW Berlin Weekly Report No. 6/2005
Table  5
Production, Value Added and Employment Induced in Production Sectors by Investment in Fixed 
Capital Formation by the Pharmaceutical Industry in 2002 





















1 01 to 05 Agriculture, forestry and fishing 2 3 2 69
2 10 to 14 Mining and quarrying  062 6 1
3 15 Food products and beverages 0 2 1 14
4 16 Tobacco products 0000
5 17 Textiles 231 3 4
6 18 Wearing apparel; furs 0002
7 19 Leather and leather products 0 0 0 3
8 20 Wood and products of wood and cork, except furniture; articles of straw and plaiting materials 4 20 7 171
9 21 Pulp, paper and paper products 0 8 2 42
10 22 Publishing, printing and recorded media 11 28 12 218
11 23 Coke, refined petroleum products and nuclear fuel 0 10 1 7
12 24.4 Pharmaceutical products 0000
13 24 (ex. 24.4) Chemicals and chemical products, except pharmaceutical products 0 17 5 58
14 25 Rubber and plastic products 23 41 3 2 5 7
15 26 Glass and other non-metallic mineral products 1 27 11 237
16 27 Basic metals 34 41 1 2 1 4
17 28 Fabricated metal products, except machinery and equipment 44 123 52 1 137
18 29 Machinery and equipment 368 426 169 2 991
19 30 Office machinery and computers 36 41 9 119
20 31 Electrical machinery and apparatus, etc. 70 126 51 849
21 32 Radio, television and communication equipment and apparatus 75 88 24 538
22 33 Medical, precision and optical instruments, watches and clocks 83 90 42 775
23 34 Motor vehicles, trailers and semi-trailers 136 185 40 612
24 35 Other transport equipment 57 57 16 289
25 36 Furniture, other manufactured goods, etc. 50 55 20 555
26 37 Material recycling 0106
27 40 Electrical energy, gas, steam and hot water and distribution of gas 0 20 9 70
28 41 Water supply 021 1 1
29 45 Construction; civil engineering and building completion 171 189 82 2 492
30 50 Sale, maintenance and repair of motor vehicles and motorcycles; retail sale of automotive fuel 48 59 31 977
31 51 Wholesale trade and commission trade, except of motor vehicles and motorcycles 92 170 103 1 806
32 52 Retail trade, except of motor vehicles and motorcycles; repair of personal and household goods 14 21 13 532
33 55 Hotel and restaurant services 0 5 2 168
34 60 Land transport; transport via pipelines 37 51 25 876
35 61 Water transport services 0102
36 62 Air transport services 084 1 9
37 63 Supporting and auxiliary transport activities; activities of travel agencies 0 32 11 240
38 64 Post and telecommunications 0 23 14 145
39 65 Financial intermediation services, except insurance and pension funding services 0 39 -3 303
40 66 Insurance and pension funding services, except compulsory social security 0 7 2 29
41 67 Activities auxiliary to financial intermediation 0 4 2 51
42 70 Real estate activities 46 75 28 5
43 71 Renting of machinery and equipment without operator and of personal and household goods 0 35 25 61
44 72 Computer and related services 169 203 151 1 752
45 73 Research and development services 0 1 1 10
46 74 Other business services 19 172 121 2 240
47 75 Public administration and defence, compulsory social security services 1 8 6 124
48 80 Education 0009
49 85 Health and social work services 0 0 0 3
50 90 Sewage and refuse disposal, sanitation and similar activities 0 5 2 26
51 91 Membership organisation services, etc. 0 4 3 80
52 92 Recreational, cultural and sporting services 28 42 25 417
53 93 Other services 076 1 3 1
54 95 Private households 0000
55 All production sectors 1 526 2 572 1 180 21 910
1 Statistical classification of goods related to economic sectors in the European Union. — 2 Estimated using the structure of goods in the economy as a whole; totals are from
the investment surveys of companies by the Federal Statistical Office. — 3 Calculated using labour coefficients, estimated on the basis of the national accounts and the surveys
of cost structures.
Sources: Federal Statistical Office; DIW Berlin calculations.DIW Berlin Weekly Report No. 6/2005  87
Direct deliveries to final demand corresponded to
value added of just under 8.3 billion euros. The indirect
value added effects amounted to 6.3 billion euros or
75.7% of direct value added. Hence value added in the
economy as a whole induced by deliveries by the phar-
maceutical industry to final demand in 2002 can be held
to amount to 14.5 billion euros.
102 000 people were employed in the pharmaceutical
industry on the direct deliveries to final demand. A fur-
ther 102 000 were employed on the production induced
by these indirect effects. The distribution of these indi-
rect effects on the producing sectors can be seen in table
4. So the total employment induced by pharmaceutical
deliveries to final demand was twice as high as the
direct employment.
The relation between the macroeconomic effects that
can be attributed to deliveries by the pharmaceutical
sector to final demand and the direct effects was of a
comparable order in all the three years considered (cf.
figure 3). In 1995 the macroeconomic effects amounted
to 60% of direct production to meet final demand for
pharmaceutical products, to 70% of the gross value
added they induced and 90% of the employment that
can be directly attributed to them. In 2002 the corre-
sponding relations were 56.7% for production, 75.7%
for gross value added and 100.2% for employment.
The effects by economic sector
Effects caused by the pharmaceutical industry on pro-
duction, value added and employment can be observed
in almost every area of production in the economy. But
considerable differences are evident in the extent of the
indirect effects and these are shown in detail in table 4.
In 2002 75% of the indirect production effects were
concentrated in only twelve sectors, as were 78% of the
sectoral value added effects and 70% of the indirect
employment effects.
Of the production sectors most strongly 'affected' by
the pharmaceutical industry (cf. figure 4) eight are in the
services sector, and with the exception of the banks they
show above-average value added ratios. This explains
the higher share of these twelve sectors in the gross
value added induced by the pharmaceutical industry
compared with the indirect production effects.
Admittedly, on average for the services sector the
labour input per output unit is higher than the labour
intensity on average for the economy as a whole, but
that does not apply to most of the services sectors
strongly used by the pharmaceutical industry. The
chemical industry (without pharmaceuticals) is second
in importance among these, and here, too, the labour
intensity is considerably below the average for the econ-
omy as a whole. So _ in deviation from the macroeco-
nomic effects _ the share of the employment indirectly
induced by the pharmaceutical industry in the twelve
most strongly affected supplier branches is lower than
the share of production.
Of the services sectors listed here only business-
related services and the wholesale trade and commission
trade show the sequence of above-average labour coeffi-
cients and value added ratios typical of services. In the
manufacturing sectors chemical products (without phar-
maceuticals) show the pattern of the various effects that
is typical of the manufacturing sector.
Conclusion
In 2000 106 000 people were employed to produce phar-
maceuticals. The analyses of the linkages between the
manufacture of pharmaceuticals and the rest of the
economy show, however, that the activities of the phar-
maceutical industry cause considerable employment in
the other production sectors. For every person employed
in the pharmaceutical industry another is employed in
the rest of the economy. So the macroeconomic impor-
Figure 3
Macroeconomic Effects of the Production of 
Pharmaceuticals in Relation to the Direct 
Effects
(%)
Sources: Federal Statistical Office; DIW Berlin calculations.
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tance of the pharmaceutical industry is therefore greater
than its direct contributions to the gross domestic prod-
uct and employment show.
As a country poor in raw materials Germany is
dependent on production that can hold a position on the
world market. That requires a high level of education,
knowledge and research. The pharmaceutical industry
contributes to this, not only by employing highly skilled
personnel and with its own R&D, but also by inducing
additional employment and value added in high-quality
services sectors. State regulation of the health system
must take these strong effects into account. 
Sources: Federal Statistical Office; DIW Berlin calculations.
Figure 4
The Supplier Sectors most Stimulated by the Pharmaceutical Industry in 2002
Shares of indirect sectoral effects of deliveries to final demand by the pharmaceutical industry in total indirect effects (%)
DIW Berlin 2005
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